COM:BRIDGEBIO
BridgeBio Pharma, Inc.
- Stock
Last Close
23.24
22/11 21:00
Market Cap
4.97B
Beta: -
Volume Today
2.05M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | -34.45M - | -15.48M 55.05% | 27.29M 276.26% | |||||
average payables | 7.70M - | 11.18M 45.26% | 8.90M 20.41% | 10.41M 17.04% | 11.72M 12.55% | 11.11M 5.24% | ||
average receivables | 9.87M - | 18.41M 86.48% | 9.41M 48.87% | |||||
book value per share | -0.63 - | -1.78 182.66% | 3.89 318.82% | 0.49 87.37% | -6.03 1,328.66% | -8.51 41.09% | -0.01 99.90% | |
capex per share | -0.01 - | -0.20 3,817.67% | -0.05 75.17% | -0.06 30.33% | -0.33 424.55% | -0.04 87.18% | -0.00 99.98% | |
capex to depreciation | -1.78 - | -74.20 4,057.53% | -2.43 - | -8.26 239.16% | -0.93 88.69% | -0.20 78.46% | ||
capex to operating cash flow | 0.01 - | 0.13 1,060.83% | 0.02 84.77% | 0.02 7.17% | 0.10 415.15% | 0.02 84.45% | 0.00 83.58% | |
capex to revenue | -0.13 - | -0.91 619.46% | -0.69 24.07% | -0.08 88.24% | -0.14 72.45% | |||
cash per share | 1.00 - | 4.72 374.03% | 5.20 9.99% | 5.15 0.96% | 5.80 12.65% | 3.20 44.79% | 0.00 99.92% | |
days of inventory on hand | -8.08K - | 4.03K 149.92% | 2.49K 38.36% | |||||
days payables outstanding | 1.29K - | 1.39K - | 1.23K 11.81% | 1.59K 29.42% | ||||
days sales outstanding | 103.40 - | 80.28 22.35% | 68.70 14.43% | |||||
debt to assets | 0.12 - | 0.17 45.56% | 0.70 312.94% | 1.71 142.56% | 2.77 62.19% | 3.18 14.86% | ||
debt to equity | -0.33 - | 0.26 179.40% | 8.56 3,144.38% | -1.99 123.23% | -1.38 30.78% | -1.28 6.68% | ||
dividend yield | 0.00 - | 0.00 - | 0.00 - | |||||
earnings yield | -0.01 - | -0.05 327.77% | -0.07 37.54% | -0.06 18.42% | -0.27 360.35% | -0.44 65.56% | -0.00 99.98% | |
enterprise value | 2.45B - | 2.16B 11.81% | 3.42B 58.17% | 8.53B 149.44% | 3.74B 56.15% | 2.47B 33.95% | 6.57T 265,957.01% | |
enterprise value over ebitda | -55.95 - | -11.82 78.88% | -12.24 3.58% | -18.19 48.66% | -6.93 61.91% | -6.99 0.79% | -11.44K 163,651.54% | |
ev to operating cash flow | -60.55 - | -15.82 73.87% | -13.49 14.77% | -21.34 58.25% | -7.51 64.80% | -5.89 21.59% | -12.46K 211,393.44% | |
ev to sales | 84.31 - | 1.03K 1,126.51% | 53.65 94.81% | 31.82 40.69% | 706.57K 2,220,559.41% | |||
free cash flow per share | -0.44 - | -1.68 278.05% | -2.46 46.81% | -3.45 40.20% | -3.78 9.63% | -2.89 23.69% | -0.00 99.89% | |
free cash flow yield | -0.02 - | -0.06 278.05% | -0.07 15.39% | -0.05 30.90% | -0.23 367.37% | -0.38 67.05% | -0.00 99.98% | |
graham net net | -0.66 - | -1.41 114.64% | 3.71 363.02% | 0.10 97.40% | -7.35 7,715.93% | -9.25 25.82% | -0.01 99.90% | |
graham number | 2.16 - | 7.52 247.73% | 14.72 95.68% | 6.73 54.28% | 24.51 264.24% | 25.32 3.30% | 0.03 99.89% | |
income quality | 0.92 - | 0.81 12.70% | 0.88 8.97% | 0.79 10.01% | 0.85 7.37% | 0.87 1.94% | 0.81 6.67% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0.04 Infinity% | 0.05 3.87% | 0.05 4.53% | |
interest coverage | -3.37K - | -72.11 97.86% | -30.38 57.88% | -12.94 57.38% | -12.39 4.26% | -5.87 52.67% | -7.47 27.37% | |
interest debt per share | 0.00 - | 0.62 438,776.92% | 1.11 79.47% | 4.51 306.88% | 12.32 172.94% | 12.26 0.47% | 0.01 99.91% | |
inventory turnover | -0.05 - | 0.09 300.31% | 0.15 62.24% | |||||
invested capital | -0.33 - | 0.26 179.40% | 8.56 3,144.38% | -1.99 123.23% | -1.38 30.78% | -1.28 6.68% | ||
market cap | 2.54B - | 2.54B 0% | 3.68B 44.82% | 8.39B 127.78% | 2.41B 71.30% | 1.12B 53.33% | 6.57T 584,720.78% | |
net current asset value | -55.60M - | -121.22M 118.03% | 444.06M 466.33% | 47.12M 89.39% | -1.04B 2,304.20% | -1.36B 31.20% | -1.41B 3.56% | |
net debt to ebitda | 2.10 - | 2.09 0.67% | 0.94 54.69% | -0.30 131.54% | -2.47 728.53% | -3.81 54.25% | -2.37 37.67% | |
net income per share | -0.33 - | -1.42 327.77% | -2.48 74.99% | -4.10 65.50% | -4.43 7.98% | -3.35 24.37% | -0.00 99.88% | |
operating cash flow per share | -0.44 - | -1.48 237.49% | -2.41 63.04% | -3.39 40.40% | -3.45 1.82% | -2.84 17.53% | -0.00 99.89% | |
payables turnover | 0.28 - | 0.26 - | 0.30 13.39% | 0.23 22.73% | ||||
receivables turnover | 3.53 - | 4.55 28.79% | 5.31 16.86% | |||||
research and ddevelopement to revenue | 5.18 - | 40.86 689.36% | 6.51 84.06% | 5.19 20.35% | 48.99 844.07% | |||
return on tangible assets | -0.31 - | -0.28 9.79% | -0.41 46.61% | -0.69 66.82% | -0.66 3.96% | -0.83 25.83% | -1.24 48.81% | |
revenue per share | 0.39 - | 0.07 81.89% | 0.48 590.81% | 0.53 9.02% | 0.00 99.99% | |||
roe | 0.53 - | 0.80 51.34% | -0.64 179.97% | -8.36 1,210.67% | 0.73 108.79% | 0.39 46.39% | 0.47 20.63% | |
roic | 0.52 - | 1.84 252.25% | -0.46 124.86% | -0.79 73.22% | -0.72 9.85% | -0.98 37.55% | -1.69 71.70% | |
sales general and administrative to revenue | 2.33 - | 17.66 659.19% | ||||||
shareholders equity per share | -0.63 - | -1.78 182.66% | 3.89 318.82% | 0.49 87.37% | -6.03 1,328.66% | -8.51 41.09% | -0.01 99.90% | |
stock based compensation to revenue | 0.53 - | 7.09 1,244.81% | 1.43 79.86% | 1.18 17.39% | 11.69 891.00% | |||
tangible asset value | -54.69M - | -101.50M 85.61% | 475.98M 568.93% | 107.89M 77.33% | -910.51M 943.96% | -1.27B 39.88% | -1.37B 7.48% | |
tangible book value per share | -0.59 - | -1.10 85.61% | 4.53 511.96% | 0.91 79.81% | -6.31 789.84% | -8.64 36.93% | -0.01 99.90% | |
working capital | 88.58M - | 412.65M 365.84% | 547.38M 32.65% | 550.97M 0.66% | 709.58M 28.79% | 387.45M 45.40% | 333.75M 13.86% |
All numbers in USD (except ratios and percentages)